Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971567116> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W1971567116 endingPage "337" @default.
- W1971567116 startingPage "337" @default.
- W1971567116 abstract "Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor Ayad K AliDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USABackground: The purpose of this study was to examine the postmarketing safety profile of aliskiren hemifumarate, a first-in-class direct renin inhibitor.Methods: The US Adverse Event Reporting System (AERS) was utilized to conduct a retrospective pharmacovigilance analysis by applying the Multi-item Gamma Poisson Shrinker data mining algorithm to calculate empiric Bayes geometric mean (EBGM) values of aliskiren-related adverse event reports. Reports received from January 2007 through December 2008 are included in this analysis.Results: In total, 1592 reports for aliskiren are identified in the AERS. Aliskiren was associated with reports of angioedema (EBGM 3.9, 95% confidence interval [CI] 3.2–4.7) and renal dysfunction (EBGM 3.4, 95% CI 2.6–4.5). Reports of hyperkalemia, dry cough, and diarrhea were also linked to aliskiren (EBGM 7.4, 95% CI 3.4–13.0, EBGM 11.0, 95% CI 7.8–14.2, EBGM 4.3, 95% CI 3.2–5.8, respectively).Conclusion: Angioedema and renal dysfunction are potential adverse events associated with exposure to aliskiren. Patients with signs and symptoms of angioedema should stop aliskiren and seek urgent medical help. Aliskiren should not be used by patients with a risk of renal impairment. Additional studies are warranted to quantify further the risk of these events in patients with hypertension.Keywords: aliskiren, postmarketing safety surveillance, adverse event reporting system" @default.
- W1971567116 created "2016-06-24" @default.
- W1971567116 creator A5014212549 @default.
- W1971567116 date "2011-08-01" @default.
- W1971567116 modified "2023-09-26" @default.
- W1971567116 title "Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor" @default.
- W1971567116 cites W1981809734 @default.
- W1971567116 cites W2009585391 @default.
- W1971567116 cites W2039594635 @default.
- W1971567116 cites W2048507943 @default.
- W1971567116 cites W2063358281 @default.
- W1971567116 cites W2068871297 @default.
- W1971567116 cites W2125836541 @default.
- W1971567116 cites W2128957326 @default.
- W1971567116 cites W2134277408 @default.
- W1971567116 cites W2157972885 @default.
- W1971567116 cites W2171818587 @default.
- W1971567116 cites W619520638 @default.
- W1971567116 cites W124248492 @default.
- W1971567116 doi "https://doi.org/10.2147/tcrm.s23889" @default.
- W1971567116 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3176166" @default.
- W1971567116 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21941439" @default.
- W1971567116 hasPublicationYear "2011" @default.
- W1971567116 type Work @default.
- W1971567116 sameAs 1971567116 @default.
- W1971567116 citedByCount "31" @default.
- W1971567116 countsByYear W19715671162012 @default.
- W1971567116 countsByYear W19715671162013 @default.
- W1971567116 countsByYear W19715671162014 @default.
- W1971567116 countsByYear W19715671162015 @default.
- W1971567116 countsByYear W19715671162016 @default.
- W1971567116 countsByYear W19715671162017 @default.
- W1971567116 countsByYear W19715671162018 @default.
- W1971567116 countsByYear W19715671162019 @default.
- W1971567116 countsByYear W19715671162020 @default.
- W1971567116 crossrefType "journal-article" @default.
- W1971567116 hasAuthorship W1971567116A5014212549 @default.
- W1971567116 hasBestOaLocation W19715671161 @default.
- W1971567116 hasConcept C126322002 @default.
- W1971567116 hasConcept C197934379 @default.
- W1971567116 hasConcept C198710026 @default.
- W1971567116 hasConcept C2777105317 @default.
- W1971567116 hasConcept C2777995640 @default.
- W1971567116 hasConcept C2779838083 @default.
- W1971567116 hasConcept C57658597 @default.
- W1971567116 hasConcept C71924100 @default.
- W1971567116 hasConcept C84393581 @default.
- W1971567116 hasConcept C98274493 @default.
- W1971567116 hasConceptScore W1971567116C126322002 @default.
- W1971567116 hasConceptScore W1971567116C197934379 @default.
- W1971567116 hasConceptScore W1971567116C198710026 @default.
- W1971567116 hasConceptScore W1971567116C2777105317 @default.
- W1971567116 hasConceptScore W1971567116C2777995640 @default.
- W1971567116 hasConceptScore W1971567116C2779838083 @default.
- W1971567116 hasConceptScore W1971567116C57658597 @default.
- W1971567116 hasConceptScore W1971567116C71924100 @default.
- W1971567116 hasConceptScore W1971567116C84393581 @default.
- W1971567116 hasConceptScore W1971567116C98274493 @default.
- W1971567116 hasLocation W19715671161 @default.
- W1971567116 hasLocation W19715671162 @default.
- W1971567116 hasLocation W19715671163 @default.
- W1971567116 hasLocation W19715671164 @default.
- W1971567116 hasOpenAccess W1971567116 @default.
- W1971567116 hasPrimaryLocation W19715671161 @default.
- W1971567116 hasRelatedWork W1777403110 @default.
- W1971567116 hasRelatedWork W1971567116 @default.
- W1971567116 hasRelatedWork W2592450025 @default.
- W1971567116 hasRelatedWork W2898266225 @default.
- W1971567116 hasRelatedWork W2982021612 @default.
- W1971567116 hasRelatedWork W3109431802 @default.
- W1971567116 hasRelatedWork W4220701557 @default.
- W1971567116 hasRelatedWork W4281861147 @default.
- W1971567116 hasRelatedWork W4310255579 @default.
- W1971567116 hasRelatedWork W4323347657 @default.
- W1971567116 isParatext "false" @default.
- W1971567116 isRetracted "false" @default.
- W1971567116 magId "1971567116" @default.
- W1971567116 workType "article" @default.